Inhibitory effect of lovastatin on human lung cancer cell proliferation by regulating the ERK1/2 and COX-2 pathways.

Transl Cancer Res · 2022 · PMC9091021 · PMID 35571660

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The results obtained from our analysis confirmed that the protein level of BCL-2 in A549 cells showed a decreasing trend with increasing concentrations of lovastatin compared to the control group, while the level of BAX increased.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.